Unknown

Dataset Information

Nucleolin expression has prognostic value in neuroblastoma patients.


ABSTRACT:

Background

Neuroblastoma (NB) represents the most frequent form of extra-cranial solid tumour of infants, responsible for 15% of childhood cancer deaths. Nucleolin (NCL) prognostic value in NB was investigated.

Methods

NCL protein expression was retrospectively evaluated in tumour samples of NB patients at diagnosis and after chemotherapy. NCL prognostic value at mRNA level was assessed in a cohort of 20 patients with stage 4 NB (qPCR20, n=20, discovery dataset) and in the MultiPlatform786 including 786 patients of all stages (validation dataset). Overall and event-free survival curves were plotted by Kaplan-Meier method and compared by log-rank test.

Findings

NCL protein, down-modulated after chemotherapy in association with features of neuroblastic differentiation,r

SUBMITTER: Cangelosi D 

PROVIDER: S-EPMC9547201 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature